McNeil Elevates Quality Management In Wake Of Tylenol, Motrin Recall
This article was originally published in The Tan Sheet
Executive SummaryMcNeil Consumer Healthcare adds executive posts for quality assurance in its response to FDA's warning about a problem with packaging materials that led to a massive recall of OTC products
You may also be interested in...
FDA shifts its scrutiny of Johnson & Johnson’s OTC drug quality control onto the firm’s consumer devices, including K-Y moisturizers, after finding shortcomings in post-market monitoring and pre-market notification. The agency’s May 22 warning letter does not cite manufacturing issues.